Biotech Assistant
Share useful research with your peers
in · Share on LinkedIn ↗
CHINA CLINICAL DEVELOPMENT / INTERNATIONAL BIOTECH

China Clinical CROs & IIT Partners

Compare China-based and China-origin CROs, international China operations, and separately labeled specialist partners for China trials and IITs.

Open the clinical CRO comparison map ↗Questions for partner selection ↓
15China-based / China-originView companies →12International CRO China operationsView companies →3Specialist / consultancy candidatesView companies →4SMO / device specialistsView companies →

How to read this directory

34 service-platform records across four categories, not 34 independent Chinese full-service CROs. Group subsidiaries and renamed platforms are identified. Company disclosures establish service claims, not independent quality certification; coverage is broad but not guaranteed exhaustive. GCP ClinPlus is featured first by editorial choice.

GCP ClinPlus is featured first, with public disclosures supporting China clinical and IIT services for international clients. GCP ClinPlus, SMO ClinPlus and Proswell are separate companies.

An IIT is investigator-initiated research, not automatically a registrational trial or a guarantee of overseas regulatory acceptance. Assess the modality, objective, institution and intended submission use separately.

NIH: China clinical research regulation sources ↗ · IQVIA: China IIT versus IND discussion ↗

Reset

China-based / China-origin

View all records

15 / 34 platform records; ordering is not a comparative performance ranking.

FEATURED · CHINA CLINICAL & IIT

GCP ClinPlus

Discloses China clinical operations, biometrics, regulatory and safety services, with explicit China IIT support for international developers, including cell and gene therapies. A US subsidiary and international partner network support cross-border engagement.

IIT evidence: IIT / investigator-led research explicitly disclosed

Full-service clinical Early-phase clinical Cell & gene therapy Oncology Data management & biostatistics Explicit IIT disclosure

Confirm before selection
  • Confirm the contracting entity, English-speaking PM, recent international sponsor references and indication-specific site resources.
  • IIT eligibility, ethics, data access, HGR responsibilities and any intended overseas data use require a project-specific assessment.

Checked: 2026-11-06 · Based on public disclosure, not a quality audit.

GCP ClinPlus ↗ · GCP ClinPlus ↗ · GCP ClinPlus ↗

Compare and save in the member map →
China-based / China-origin

Tigermed

China-origin global clinical CRO with a disclosed Chinese investigator network and cross-regional development services. Historical offering documents reference IITs; confirm current indication-specific IIT staffing and scope.

IIT evidence: Historical IIT disclosure; current scope to confirm

Full-service clinical Cross-border / multicentre trials Oncology Data management & biostatistics

Confirm before selection
  • Confirm the contracting entity, English-speaking PM, recent international sponsor references and indication-specific site resources.
  • IIT eligibility, ethics, data access, HGR responsibilities and any intended overseas data use require a project-specific assessment.

Checked: 2026-11-06 · Based on public disclosure, not a quality audit.

Tigermed ↗ · Tigermed ↗ · Tigermed ↗

Compare and save in the member map →
China-based / China-origin

ClinChoice

China-origin global CRO. Its China service page describes Phase I–IV work, site start-up, operations and biometrics for local and global sponsors. Global trial experience does not establish a specific IIT track record.

IIT evidence: IIT capability not established by reviewed sources

Full-service clinical Cross-border / multicentre trials Oncology Data management & biostatistics

Confirm before selection
  • Confirm the contracting entity, English-speaking PM, recent international sponsor references and indication-specific site resources.
  • IIT eligibility, ethics, data access, HGR responsibilities and any intended overseas data use require a project-specific assessment.

Checked: 2026-11-06 · Based on public disclosure, not a quality audit.

ClinChoice ↗ · ClinChoice ↗

Compare and save in the member map →
China-based / China-origin

Caidya

International CRO incorporating China-origin dMed. Discloses China operational strength and connected development between China, the US and Europe.

IIT evidence: IIT capability not established by reviewed sources

Full-service clinical Cross-border / multicentre trials Oncology Data management & biostatistics

Confirm before selection
  • Confirm the contracting entity, English-speaking PM, recent international sponsor references and indication-specific site resources.
  • IIT eligibility, ethics, data access, HGR responsibilities and any intended overseas data use require a project-specific assessment.

Checked: 2026-11-06 · Based on public disclosure, not a quality audit.

Caidya ↗

Compare and save in the member map →
China-based / China-origin

Harvest Integrated Research Organization (HiRO)

Cross-border CRO with China operations. Team biographies reference Phase I–IV and IIT experience. Staff experience is not proof of company-level IIT delivery; verify the contracting entity and China project lead.

IIT evidence: Team IIT experience; company cases to confirm

Full-service clinical Cross-border / multicentre trials Early-phase clinical Data management & biostatistics

Confirm before selection
  • Confirm the contracting entity, English-speaking PM, recent international sponsor references and indication-specific site resources.
  • IIT eligibility, ethics, data access, HGR responsibilities and any intended overseas data use require a project-specific assessment.

Checked: 2026-11-06 · Based on public disclosure, not a quality audit.

Harvest Integrated Research Organization (HiRO) ↗ · Harvest Integrated Research Organization (HiRO) ↗

Compare and save in the member map →
China-based / China-origin

Pharmaron Clinical

China clinical platform within a global development network, with operations linked to SMO and recruitment teams. Distinguish China delivery from the group’s US and UK early-phase facilities.

IIT evidence: IIT capability not established by reviewed sources

Full-service clinical Cross-border / multicentre trials Early-phase clinical Data management & biostatistics

Confirm before selection
  • Confirm the contracting entity, English-speaking PM, recent international sponsor references and indication-specific site resources.
  • IIT eligibility, ethics, data access, HGR responsibilities and any intended overseas data use require a project-specific assessment.

Checked: 2026-11-06 · Based on public disclosure, not a quality audit.

Pharmaron Clinical ↗ · Pharmaron Clinical ↗

Compare and save in the member map →
China-based / China-origin

R&G PharmaStudies

China clinical CRO with biometrics and trial management capabilities. A Medidata partnership announcement supports its clinical technology and data-standardization approach; confirm international sponsor references and IIT staffing directly.

IIT evidence: IIT capability not established by reviewed sources

Full-service clinical Cross-border / multicentre trials Data management & biostatistics

Confirm before selection
  • Confirm the contracting entity, English-speaking PM, recent international sponsor references and indication-specific site resources.
  • IIT eligibility, ethics, data access, HGR responsibilities and any intended overseas data use require a project-specific assessment.

Checked: 2026-11-06 · Based on public disclosure, not a quality audit.

R&G PharmaStudies ↗ · R&G PharmaStudies ↗

Compare and save in the member map →
China-based / China-origin

Boji Medical (BojiMed)

Offers clinical operations and China–US registration services, with US development through BioTrialMed. For inbound China work, confirm local delivery, English communication and quality responsibilities separately.

IIT evidence: IIT capability not established by reviewed sources

Full-service clinical Cross-border / multicentre trials Early-phase clinical

Confirm before selection
  • Confirm the contracting entity, English-speaking PM, recent international sponsor references and indication-specific site resources.
  • IIT eligibility, ethics, data access, HGR responsibilities and any intended overseas data use require a project-specific assessment.

Checked: 2026-11-06 · Based on public disclosure, not a quality audit.

Boji Medical (BojiMed) ↗ · Boji Medical (BojiMed) ↗

Compare and save in the member map →
China-based / China-origin

JOINN Clinical

JOINN’s corporate disclosures include clinical trials and pharmacovigilance. Verify the clinical team and contracting entity; group GLP toxicology credentials do not establish clinical GCP execution capability.

IIT evidence: IIT capability not established by reviewed sources

Full-service clinical Early-phase clinical Data management & biostatistics

Confirm before selection
  • Confirm the contracting entity, English-speaking PM, recent international sponsor references and indication-specific site resources.
  • IIT eligibility, ethics, data access, HGR responsibilities and any intended overseas data use require a project-specific assessment.

Checked: 2026-11-06 · Based on public disclosure, not a quality audit.

JOINN Clinical ↗ · JOINN Clinical ↗

Compare and save in the member map →
China-based / China-origin

Frontage Clinical Services

Clinical and laboratory platform with China and North America operations, including early-phase clinical services and biometrics. Assess early development fit separately from full-service registrational trial management.

IIT evidence: IIT capability not established by reviewed sources

Early-phase clinical Data management & biostatistics

Confirm before selection
  • Confirm the contracting entity, English-speaking PM, recent international sponsor references and indication-specific site resources.
  • IIT eligibility, ethics, data access, HGR responsibilities and any intended overseas data use require a project-specific assessment.

Checked: 2026-11-06 · Based on public disclosure, not a quality audit.

Frontage Clinical Services ↗ · Frontage Clinical Services ↗

Compare and save in the member map →
China-based / China-origin

H&J CRO International

China full-service clinical CRO disclosing a Shanghai entity and US subsidiary, targeting overseas-sponsored China studies. Confirm current staffing, sponsor references and delivery entity.

IIT evidence: IIT capability not established by reviewed sources

Full-service clinical Cross-border / multicentre trials Data management & biostatistics

Confirm before selection
  • Confirm the contracting entity, English-speaking PM, recent international sponsor references and indication-specific site resources.
  • IIT eligibility, ethics, data access, HGR responsibilities and any intended overseas data use require a project-specific assessment.

Checked: 2026-11-06 · Based on public disclosure, not a quality audit.

H&J CRO International ↗

Compare and save in the member map →
China-based / China-origin

Proswell Medical

China clinical CRO with a Medidata partner profile and a Micron alliance announcement supporting international collaboration. Proswell is a separate company from GCP ClinPlus.

IIT evidence: IIT capability not established by reviewed sources

Full-service clinical Data management & biostatistics

Confirm before selection
  • Confirm the contracting entity, English-speaking PM, recent international sponsor references and indication-specific site resources.
  • IIT eligibility, ethics, data access, HGR responsibilities and any intended overseas data use require a project-specific assessment.

Checked: 2026-11-06 · Based on public disclosure, not a quality audit.

Proswell Medical ↗ · Proswell Medical ↗ · Proswell Medical ↗

Compare and save in the member map →
China-based / China-origin

Clinical Service Center (CSC)

China-origin CRO disclosing international branches and operations, regulatory, writing and biometrics services. Public materials describe China–US and multi-country submissions; confirm inbound China and IIT experience.

IIT evidence: IIT capability not established by reviewed sources

Full-service clinical Cross-border / multicentre trials Data management & biostatistics

Confirm before selection
  • Confirm the contracting entity, English-speaking PM, recent international sponsor references and indication-specific site resources.
  • IIT eligibility, ethics, data access, HGR responsibilities and any intended overseas data use require a project-specific assessment.

Checked: 2026-11-06 · Based on public disclosure, not a quality audit.

Clinical Service Center (CSC) ↗ · Clinical Service Center (CSC) ↗

Compare and save in the member map →
China-based / China-origin

Giant Med-Pharma Services

China clinical CRO whose English site describes domestic and overseas clients and hospital-initiated research involving international sites. This supports investigator-led experience, with current commercial IIT scope to confirm.

IIT evidence: IIT / investigator-led research explicitly disclosed

Full-service clinical Cross-border / multicentre trials Oncology Data management & biostatistics Explicit IIT disclosure

Confirm before selection
  • Confirm the contracting entity, English-speaking PM, recent international sponsor references and indication-specific site resources.
  • IIT eligibility, ethics, data access, HGR responsibilities and any intended overseas data use require a project-specific assessment.

Checked: 2026-11-06 · Based on public disclosure, not a quality audit.

Giant Med-Pharma Services ↗ · Giant Med-Pharma Services ↗

Compare and save in the member map →
China-based / China-origin

SIIP Clinical Research / Shanghai Yilinsi

SIIP’s official business page identifies Shanghai Yilinsi clinical services covering Phase I–IV, human PK, bioequivalence and international multicentre studies. Confirm English project staffing and recent overseas sponsor references.

IIT evidence: IIT capability not established by reviewed sources

Full-service clinical Cross-border / multicentre trials Early-phase clinical Data management & biostatistics

Confirm before selection
  • Confirm the contracting entity, English-speaking PM, recent international sponsor references and indication-specific site resources.
  • IIT eligibility, ethics, data access, HGR responsibilities and any intended overseas data use require a project-specific assessment.

Checked: 2026-11-06 · Based on public disclosure, not a quality audit.

SIIP Clinical Research / Shanghai Yilinsi ↗

Compare and save in the member map →

Partner-selection questions for international biotechs

  1. Delivery team: who is the named English-speaking project manager, which China entity contracts, and which functions are subcontracted?
  2. Relevant experience: request recent international sponsor references, indication/modality-matched case studies and named investigator/site availability.
  3. IIT fit: agree the investigator and institution roles, study governance, scientific objective and intended downstream use of the data before selecting a pathway.
  4. Quality and safety: review the quality system, audit history, monitoring plan, medical monitoring, PV and access to source records.
  5. Data and cross-border use: agree ownership, English outputs, database specifications, HGR/data responsibilities and any proposed overseas submission use.
  6. Execution and budget: compare site activation assumptions, recruitment feasibility, itemized costs, milestones, dependencies and change-control terms.

Use the directory for partner discovery and comparison. Investigators, institutions, sponsors and relevant professional teams must define the pathway and responsibilities for each study.

AI assistant ↗